Skip to main content
OpenTrials

Clinical trial condition

Central Nervous System Bacterial Infections

Explore clinical trials studying Central Nervous System Bacterial Infections. Study availability and eligibility vary by location and protocol.

178 public trials 16 recruiting studies
Refine in advanced search Browse all conditions

Central Nervous System Bacterial Infections trial results

Completed

Study of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Children Aged 2 to 9 Years

NCT03077438

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Central Nervous System Bacterial Infections, +12 more
Locations
  • Investigational Site Birmingham, Alabama, United States
  • Investigational Site Dothan, Alabama, United States
  • Investigational Site Tucson, Arizona, United States
  • Investigational Site Jonesboro, Arkansas, United States
View all 36 locations
View Trial Details
Completed

Biomarker for Duchenne Muscular Dystrophy

NCT02994030

Conditions
Atrophy, Bacterial Infections, Bacterial Infections and Mycoses, +46 more
Locations
  • University Hospital Center Mother Teresa Tirana, Albania
  • Department of Pediatric,Faculty of Medicine, Alexandria University Children's Hospital Alexandria, Egypt
  • Ain Shams University-Medical Genetics Cairo, Egypt
  • Ain Shams University Cairo, Egypt
View Trial Details
Completed

Antibody Persistence, and Safety and Tolerability of a Booster Dose of the Meningococcal B Vaccine After the Completion of the Vaccination Course in Study V72_28

NCT01894919

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Central Nervous System Bacterial Infections, +13 more
Locations
  • Site 34, General Pediatric Practice Somorjai Debrecen, Bajcsi Ut 32, Hungary
  • Site 35, Praxis Dr Eva Kovacs Szeged, Csongradi Sgt 63, Hungary
  • Site 36, General Practice Dr Edit Oszlacs Szeged, Debreceni Utca 10-14, Hungary
  • Site 37, Praxis Dr Julianna Kovacs Bordány, Honved Utca 2, Hungary
View all 17 locations
View Trial Details
Completed

Optimizing Treatment to Improve TBM Outcomes in Children

NCT02958709

Conditions
Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +14 more
Locations
  • Byramji Jeejeebhoy Government Medical College and Sassoon Hospital Pune, Maharashtra, India
  • National Institute of Research in TB and Institute of Child Health Chennai, Tamil Nadu, India
  • UNC Project- Malawi Lilongwe, Lilongwe District, Malawi
View Trial Details
Completed

A Pilot Study Evaluating Penicillin G and Ceftriaxone as Therapies for Presumed Neurosyphilis in HIV Seropositive Individuals

NCT00000648

Conditions
AIDS-Related Complex, Acquired Immunodeficiency Syndrome, Bacterial Infections, +25 more
Locations
  • Univ of Alabama at Birmingham Birmingham, Alabama, United States
  • Univ of California / San Diego Treatment Ctr San Diego, California, United States
  • San Francisco Veterans Administration Med Ctr San Francisco, California, United States
  • Harbor UCLA Med Ctr Torrance, California, United States
View all 42 locations
View Trial Details
Completed

Linezolid, Aspirin and Enhanced Dose Rifampicin in HIV-TBM

NCT03927313

Conditions
Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +16 more
Locations
  • Livingstone Hospital Port Elizabeth, Eastern Cape, South Africa
  • Mitchells Plain Hospital Cape Town, Western Cape, South Africa
  • Groote Schuur Hospital Cape Town, Western Cape, South Africa
  • New Somerset Hospital Cape Town, Western Cape, South Africa
View Trial Details
Completed

Febrile Infants - Diagnostic Assessment and Outcome

NCT04196192

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Central Nervous System Bacterial Infections, +13 more
Locations
  • Children's Health Ireland Dublin, Ireland
  • Royal Belfast Hospital for Sick Children Belfast, Northern Ireland, United Kingdom
  • Bristol Royal Children's Hospital Bristol, United Kingdom
  • Royal Hospital for Children Glasgow Glasgow, United Kingdom
View Trial Details
Completed

A Study to Investigate the Safety and Immunogenicity of Different Formulations of GSK Biologicals' Meningococcal ACWY Conjugate Vaccine (GSK3536820A and Menveo) Administered to Healthy Adolescents and Young Adults 10 to 40 Years of Age

NCT03433482

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Central Nervous System Bacterial Infections, +11 more
Locations
  • GSK Investigational Site Salvador, Estado de Bahia, Brazil
  • GSK Investigational Site Natal, Rio Grande do Norte, Brazil
  • GSK Investigational Site Rio de Janeiro, Brazil
  • GSK Investigational Site São Paulo, Brazil
View all 49 locations
View Trial Details

Related conditions